Ibruxen 140 mg (Ibrutinib) Capsules

Ibruxen (Ibrutinib) 140 mg Capsules is a targeted oral anticancer medicine that helps slow the growth and spread of abnormal B lymphocytes by inhibiting Bruton's Tyrosine Kinase (BTK). It is prescribed for specific hematologic malignancies and certain immune-related conditions under the supervision of an experienced healthcare professional.

Therapeutic Uses

• Treatment of Chronic Lymphocytic Leukemia (CLL).
• Management of Small Lymphocytic Lymphoma (SLL).
• Treatment of Mantle Cell Lymphoma (MCL) in eligible patients.
• Management of Waldenström Macroglobulinemia (WM).
• Treatment of Marginal Zone Lymphoma (MZL) in patients who require systemic therapy.
• Management of Chronic Graft-versus-Host Disease (cGVHD) after failure of one or more prior systemic therapies.
• Helps reduce disease progression and improve clinical outcomes in appropriate patients when used as prescribed.

Each capsule contains:

• Active Ingredient: Ibrutinib
• Strength: 140 mg per capsule

Pharmacological Class

• Bruton's Tyrosine Kinase (BTK) Inhibitor
• Targeted Anticancer Agent
• Oral Oncology Medicine

Composition Information

Each capsule contains Ibrutinib 140 mg along with pharmaceutical-grade inactive ingredients that support capsule stability, consistency, and oral administration. The complete list of excipients may vary depending on the manufacturer.

Always use this medicine exactly as prescribed by a qualified healthcare professional. The dose varies depending on the condition being treated, the patient's health status, and concurrent medications.

Recommended Administration

• Take orally once daily at approximately the same time each day.
• Swallow the capsule whole with a full glass of water.
• Do not open, crush, chew, or break the capsule.
• May be taken with or without food.
• Continue treatment for as long as recommended by your physician.

Missed Dose

• If a dose is missed, take it as soon as you remember on the same day.
• If it is almost time for the next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
• Do not take two doses at the same time to make up for a missed dose.

Important Administration Advice

• Regular blood tests and clinical monitoring may be required during treatment.
• Dose adjustments or temporary interruption may be necessary if significant side effects occur.
• Avoid grapefruit, Seville oranges, and their juices, as they may increase Ibrutinib levels in the body.
• Do not stop treatment without consulting your healthcare provider.